Pauline Funchain

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

January, 2025

Pauline Funchain

Oct 20, 2024, 12:36 | Blog

Pauline Funchain: Academic NaNoWriMo returns in 2 weeks

National Novel Writing Month (NaNoWriMo) is a nonprofit organization that provides tools, structure, community, and…

Sep 9, 2024, 08:07 | Blog

Petros Grivas: Vision and exchange of ideas on how to tackle Immune-Related Adverse Events

Petros Grivas shared a post on X: "Fantastic to join the amazing ASPIRE virtual meeting with…

Aug 15, 2024, 12:03 | Blog

Afreen Shariff: Cancer treatments and the Heart

Afreen Shariff, Board Member Association of Cancer Care Centre, shared a post on LinkedIn: “Cancer…

Jul 13, 2024, 18:03 | Blog

Afreen Shariff: Adrenal Insufficiency - What patients need to know

Afreen Shariff, Board Member Association of Cancer Care Centre, shared on LinkedIn: "Season 2: Episode…

Jun 6, 2024, 23:49 | Blog

Pauline Funchain: For everyone with an interest in ASPirE, DM me

Pauline Funchain, Co-director of the Skin Cancer Genomics Program, shared a post on X: "Yes correct…

All: 5 Posts: 1 - 100

'

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

'

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

'

Monica Bertagnolli is ending her tenure as NIH director

'

Karen Knudsen: Clinical trials are the most advanced form of cancer care

'

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023